Maturity Onset Diabetes of the Young – An Overview of Common Types. A Review

Open access


Background and aims: Maturity Onset diabetes in Young (MODY) is an autosomal dominant disease and according to an estimate, the MODY cases are 2% of all the diabetic cases. The objective was to review the common types of MODY reported in literature in context to their geographical areas. Material and method: For literature search, PubMed data base was used. The key word was “Maturity onset diabetes of the young”. The articles were reviewed by titles and if found relevant, the abstract and full article (if available) were retrieved. The studies that were published in English, presented original data and describe type of MODY were included. The information related to author, year of publication and type of MODY was extracted in excel sheet. Results: A total of 1135 studies resulted which were reviewed, and 206 articles were finally selected. The studies were grouped according to the regions i.e. Asia, Europe, America, Africa and Australia & Oceania. The MODY 2 was most prevalent in regions i.e. Asia, Europe, America and Australia & Oceania followed by MODY 3. When analysed according to countries, MODY 2 was found prevalent in India, Korea, UK, Italy, Spain, Czech Republic, Canada and Brazil while MODY 3 was common in Japan, China, France Norway and Germany. Conclusion: The MODY 2 was most common. The data from south Asian countries including Pakistan is lacking. As there is a huge burden of diabetes in the country so there is a dire need to do large scale studies on MODY in the country.

1. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturityonset diabetes of the young. N Engl J Med 345(13): 971-980, 2001

2. Singh R, Pearson ER. The importance of making a genetic diagnosis of diabetes. Can J Diabetes 30: 183- 190, 2006

3. Van der Zwaag AM, Weinreich SS, Bosma AR, et al. Current and best practices of genetic testing for maturity onset diabetes of the young: views of professional experts. Public health genomics 18(1): 52-59, 2015

4. DellaManna T, Silva MR, Chacra AR, et al. Clinical follow-up of two Brazilian subjects with glucokinase-MODY (MODY2) with description of a novel mutation. Arq Bras Endocrinol Metab 56(8): 490-495, 2012

5. Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab 4(4): 200-213, 2008

6. Owen KR. Monogenic diabetes: old and new approaches to diagnosis. Clin Med (Lond) 13(3): 278-281, 2013

7. McDonald TJ, Ellard S. Maturity onset diabetes of the young: identification and diagnosis. Ann Clin Biochem 50(Pt 5): 403-415, 2013

8. Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 362(9392): 1275-1281, 2003

9. Naylor R, Philipson LH. Who should have genetic testing for maturity-onset diabetes of the young? Clin Endocrinol (Oxf) 75(4): 422-426, 2011

10. Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S. Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53(12): 2504-2508, 2010

11. Shepherd M, Pearson ER, Houghton J, Salt G, Ellard S, Hattersley AT. No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas. Diabetes care 26(11): 3191-3192, 2003

12. Fajans SS, Brown MB. Administration of sulfonylureas can increase glucose-induced insulin secretion for decades in patients with maturity-onset diabetes of the young. Diabetes care,16(9): 1254-1261, 1993

13. Shepherd M, Shields B, Ellard S, Rubio- Cabezas O, Hattersley AT. A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients. Diabet Med 26(4): 437-441, 2009

14. Velho G, Blanche H, Vaxillaire M, et al. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia 40(2): 217-224, 1997

15. Schnyder S, Mullis PE, Ellard S, Hattersley AT, Fluck CE. Genetic testing for glucokinase mutations in clinically selected patients with MODY: a worthwhile investment. Swiss medical weekly 135(23-24): 352-356, 2005

16. Bonnefond A, Philippe J, Durand E, et al. Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene. PloS one, 7(6): e37423, 2012

17. Chambers C, Fouts A, Dong F, et al. Klingensmith G et al: Characteristics of maturity onset diabetes of the young in a large diabetes center. Pediatr diabetes 17(5): 360-367, 2016

18. Valentinova L, Beer NL, Stanik J, et al. Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia. PloS One 7(4): e34541, 2012

19. Pihoker C, Gilliam LK, Ellard S, et al. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth. J Clin Endocrinol Metab 98(10): 4055-4062, 2013

20. Fowaad B, Ali SS, Zain Majid. MODY (Maturity onset diabetes of the young). JPMA 63, 2013

21. Attiya K, Sahar F, Ismail M, Qaisar M, Amara J. Linkage Analysis Of First Six Mody Genes To Known Loci And Screening Of Three Most Prevalent MODY Genes In Pakistani Population International Journal of Genetics 3(1): 35-46, 2011

22. Negahdar M, Aukrust I, Molnes J, et al. GCKMODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, selfassociation and cellular degradation. Mol Cell Endocrinol 382(1): 55-65, 2014

Romanian Journal of Diabetes Nutrition and Metabolic Diseases

The Journal of Romanian Society of Diabetes Nutrition and Metabolic Diseases

Journal Information

CiteScore 2017: 0.11

SCImago Journal Rank (SJR) 2017: 0.122
Source Normalized Impact per Paper (SNIP) 2017: 0.077


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 146 146 28
PDF Downloads 121 121 29